Maxion Therapeutics
Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.
2
Funding Rounds
$88.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Mc******** |
|
- | |
| An**** Ka**** Ve***** |
|
- |
Funding series
Funding Series Analysis
The company Maxion Therapeutics has raised a total of $72m in funding over 2 rounds.
Key Insights:
- Maxion Therapeutics Series A Round, March 2025: $72m
- Maxion Therapeutics Series A round, February 19, 2023: $16m
Maxion Therapeutics Series A Round, March 2025
$72m
Maxion Therapeutics Series A round, February 19, 2023
$16m